Lemtrada (LEM-trah-dah, alemtuzumab) will be a new IV option for treating multiple sclerosis (MS)

Lemtrada (LEM-trah-dah, alemtuzumab) will be a new IV option for treating multiple sclerosis (MS) in Canada.

Think of Lemtrada as an alternative to interferon beta (Rebif, etc). They work to reduce disease relapses.

Expect some patients to prefer Lemtrada. It's given as an IV infusion YEARLY...instead of a self-administered injection WEEKLY or more often like interferon beta.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote